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Abstract 
Purpose: To synthesize some alkyl derivatives of carbazole and evaluate their in vitro inhibitory effect 
on alpha amylase and alpha glucosidase. 
Methods: Synthesis of methylcarbazole, ethylcarbazole, propylcarbazole and butylcarbazole was 
carried out using acid-catalysed alkylation method while in vitro inhibitory assay on alpha amylase and 
alpha glucosidase enzymes on the synthesized compounds was evaluated using standard procedures. 
Acarbose was used as the reference compound. 
Results: For carbazole, methylcarbazole, ethylcarbazole, propylcarbazole and butylcarbazole, the IC50 
values of alpha amylase inhibitory assay were 87.47, 50.23, 47.20, 42.36 and 42.11 µg/mL respectively. 
IC50 values of alpha glucosidase inhibitory assay for ethylcarbazole, propylcarbazole and butylcarbazole 
were 205.30, 153.93 and 152.90 µg/mL, respectively. Carbazole and methylcarbazole had no inhibitory 
effect on this enzyme but the reference drug (acarbose) had a better inhibitory effect towards the two 
enzymes than the synthesized products.  
Conclusion: Some alkyl-carbazoles with anti-diabetic effect have been successfully synthesised. 
Alkylation of carbazole increased the alpha amylase inhibitory effect of carbazole. The inhibitory effect is 
directly proportional to the chain length of the alkyl group. 
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Diabetes mellitus (DM) is a metabolic disorder [1] 
which is the fourth main cause of death in most 
developed countries and one of the leading 
causes of kidney failure, heart attack, blindness 
and lower limb amputation. It has been projected 
by  International Diabetes Federation that about 
330 million people will be diabetic by the year 
2025, if adequate measures are not taken, and 
over 75 % of this will be in developing countries 
as compared with 62 % in 1995 [2]. One 
promising therapeutic approach is to decrease 
hyperglycaemia by decreasing the postprandial 
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rise in blood glucose concentration. This is 
achieved by retarding and reducing the digestion 
and absorption of ingested carbohydrates 
through the inhibition of carbohydrate hydrolyzing 
enzymes such as α-amylase and α- glucosidase 
[3]. Thus, the search for new leads for 
antidiabetic drugs with lower cost and better 
efficiency has therefore become a matter of 
major priority. 
 
Carbazole and its derivatives are important type 
of nitrogen containing heterocyclic compounds 
that are widespread in nature [4]. The chemistry 
and biology of carbazole have attracted an 
increasing interest over the last 50 years.  The 
presence of a desirable electronic and charge 
transport properties, and also large pie-
conjugated system in carbazole make the 
introduction of various functional groups into the 
structurally rigid carbazolyl ring easy, resulting in 
the extensive potential application of carbazole in 
the field of medicinal chemistry [5]. Some 
carbazole derivatives are known to possess 
anticancer, antimicrobial, anti HIV, 
antihypertensive, antiparkinsonian, antipsychotic, 
 anti-emetic and antidiabetic activities [6]. 
Some antidiabetic compounds such as 
tetrahydroalstonine, lochnerinine, vindoline, 
harmine, reserpine, vincanidine and vinervine 
obtained from plants have carbazole-like nucleus 
which may be essential to their antidiabetic 
activity.   
 
This work was therefore undertaken to 
synthesise and test some alkyl-carbazole 
compounds for their antidiabetic activity by 
evaluating their inhibitory effects on alpha 
amylase and alpha glucosidase activities. This 
could provide a ‘lead’ to the discovery of novel 
antidiabetic drugs.  
    
EXPERIMENTAL 
 
Carbazole and alkyliodide were procured from 
Sigma-Aldrich, U.S.A. (CAS No: 86-74-8) and 
Kermel, India, respectively. 
 
Synthesis of alkylcarbazole compounds 
 
Alkylation of carbazole was carried out using acid 
catalysed synthesis method: carbazole (2.5g, 10 
mmol) was dissolved in conc. Sulphuric acid (40 
mL) and stirred vigorously in a round-bottomed 
flask for 2 h using a magnetic stirer followed by 
addition of iodoalkane (0.1 mol). The reaction 
medium was suspended in ice and stirring 
continued for 5 h. This was rinsed into 100 mL 
iced water using 10 mL conc. sulphuric acid and 
stirred for 30 min in a cool water bath. 100 mL of 
conc. ammonia was further added to basify the 
medium and was allowed to stand for 2 h. The 
cooled reaction medium was extracted using 50 
mL acetone and was volatilized at room 
temperature to obtain crude alkylcarbazole. 
 
Analysis of the compounds 
 
The crude alkylcarbazole was purified by column 
chromatography using silica-gel (60-120 mesh). 
Elution was done with the following solvent 
systems: n-hexane (100 %), n-
hexane:chloroform (90:10v/v to 10:90v/v), 
chloroform (100%), chloroform:acetone (90:10v/v 
to 10:90v/v), and acetone (100%). Alkylcarbazole 
was obtained in the chloroform:acetone 
(30:70v/v) solvent system. TLC analysis of the 
alkyl carbazole fraction carried out on silica gel 
precoated plate (0.25mm) using toluene: ethyl 
acetate (7:2v/v) as mobile phase produced one 
spot. 
 
Each of the synthesized compounds (10 mg) was 
dissolved in 25 mL of cyclohexane and pH of the 
solution was determined using Luton Electronic 
pH meter. The melting pint was also determined 
using the Electrothermal Melting Point Apparatus 
(England. CAT. No. 1A6304).  
 
The synthesized compounds were each 
dissolved in chloroform and the absorbance was 
measured at wavelength 200-400 nm using 
Spectro UV-VIS Dual Beam (8 Auto Cell UVS-
270; Lambomed, Inc, USA). FTIR spectra of the 
synthesized compounds were obtained using 
FTIR-8400S Fourier Transform Infrared 
Spectrophotometer. 
 
Ten milligram each of synthesized compound 
was analysed in GCMS equipment (GCMS-
QP2010 PLUS) for molecular weight elucidation 
with the following acquisition parameters: Oven 
temperature programme (temperature and hold 
time, 70 oC and 280 oC, 0 and 5 minutes, 
respectively); Column flow(1.80mL/min); Total 
flow (40.8mL/min); purge flow (3 mL/min); 
washing volume (8 µL); ion source temperature 
(200 oC); MS (start time, 3 mins, end time, 24 
mins, event time, 0.50s). Identification of the 
compounds was done using the database of 
National Institute of Science and Technology. 
 
Evaluation of alpha-amylase inhibitory 
activity 
 
Assay was carried out according to the method 
reported by Sindhu et al [7]. The assay mixture 
containing 200 µL of 0.02 M sodium phosphate 
buffer, 20 µL of enzyme and the synthesized 
products in concentration range 20-100 µg/mL 
were incubated for 10 minutes at room 
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temperature followed by addition of 200 µL of 
starch in all test tubes. The reaction was 
terminated with addition of 400 µL 
dinitrosalicyclic acid reagent and placed in boiling 
water bath for 5 min, cooled and diluted with 15 
mL of distilled water and absorbance was 
measured at 540 nm. The control sample was 
prepared without any synthesized product. The 
percentage Inhibition was calculated as: 
 
Inhibition (%) = (Acontrol - Acompound) x 100/Acontrol 
 
The concentration of alkylcarbazole required to 
inhibit 50 % of α-amylase activity was defined by 
the IC50 value determined from plot of percent 
inhibition versus log inhibitor concentration and 
was calculated by nonlinear regression analysis 
from the mean inhibitory values. Acarbose was 
used as the reference alpha-amylase inhibitor 
(positive control) and all tests were performed in 
triplicate. 
 
Evaluation of alpha-glucosidase inhibitory 
activity 
 
Alpha glucosidase inhibition assay was 
performed as reported by Adefegha and Oboh 
[8]. Alpha glucosidase was dissolved in 100 mM 
phosphate buffer (pH =6.8) and was used as the 
enzyme extract. p-Nitrophenyl-α-D-
glucopyranoside was used as the substrate. 
Synthesized product were used in the 
concentration ranging from 20-100 µg/mL. 
Different concentrations of synthesized products 
were mixed with 320 µL of 100 mM phosphate 
buffer for 5 min. 3 mL of 50 mM sodium 
hydroxide was added to the mixture and the 
absorbance was read at 410 nm. The control 
samples were prepared without any synthesized 
products. The percentage inhibition was 
calculated as: 
 
Inhibition (%) = (Acontrol - Acompound) x 100/Acontrol 
 
The concentration of alkylcarbazole require to 
inhibit 50% of α-amylase activity was defined by 
the IC50 value determined from plot of percent 
inhibition versus log inhibitor concentration and 
was calculated by nonlinear regression analysis 
from the mean inhibitory values. Acarbose was 
used as the reference alpha-amylase inhibitor 





Methylcarbazole: Rf , 0.68; (pH , 6.80); Melting 
points, 207-209 oC; λmax in chloroform and 
absorbance (309.00 nm, 1.979); IR absorption: 
3423.76 (N-H), 1643.41 (C=C (Alkene)), 1452.45 
(C=C (Aromatic)), 1449.55 (-CH3 (bend)); 
Formula: C13H11N. Mol 182. GCMS 
Fragmentation: (m/e, Fragment) – 15 (CH3 
(methyl)), 167 (C12H9N (Carbazole)), 168 
(C12H9N M+1), 181 (C13H11N (methylcarbazole)), 
182 (C13H11N M+1). 
 
Ethylcarbazole: Rf, 0.66; (pH, 6.33); Melting 
point, 142-145 oC; λmax in chloroform and 
absorbance (306.00 nm, 1.979); IR absorption: 
3417.97 (N-H), 2892.04 (C-H Alkane (stretch)), 
1627.01 (C=C (Aromatic)), 1465.17 (C=C 
(bend)), 1449.72 (-CH3 (bend)); Formula: 
C14H13N. Mol Weight: 195. GCMS 
Fragmentation: (m/e, Fragment) - 15 (CH3 
(methyl)), 29 (CH2CH3 (ethyl)), 119 (C8H9N 
(indole)), 167 (C12H9N (Carbazole)), 195 
(C14H13N (ethylcarbazole)), Ethylcarbazole. 
 
Propylcarbazole: Rf, 0.65; (pH, 5.72); Melting 
points, 120-123oC; λmax in chloroform and 
absorbance (346.00 nm, 1.915); IR absorption: 
3427.62 (N-H), 2925.15 (C-H Alkane (stretch)), 
1642.44 (C=C (Aromatic)), 1461.43 (-CH2 
(bend)), 1345.39 (-CH3 (bend)); Formula: 
C15H15N. Mol Weight: 209. GCMS 
Fragmentation: (m/e, Fragment) - 15 (CH3 
(methyl)), 29 (CH2CH3 (ethyl)), 43 (CH2CH2CH3 
(propyl)), 119 (C8H9N (indole)), 167 (C12H9N 
(Carbazole)), 209 (C15H15N (propylcarbazole). 
 
Tert-butylcarbazole: Rf, 0.63; pH, 5.46; Melting 
points, 96-99 oC; λmax in chloroform and 
absorbance (350.00 nm, 1.928); IR absorption: 
3417.01(N-H), 2878.77 (C-H Alkane (stretch)), 
1634.73 (C=C (Aromatic)), 1464.66 (-CH2 
(bend)), 1449.55 (-CH3 (bend)); Formula: 
C16H17N. Mol Weight: 223. GCMS 
Fragmentation: (m/e, Fragment) - 15 (CH3 
(methyl)), 27 (CCH3), 42 (C (CH3)2), 57 (C 
(CH3)3), 119 (C8H9N (indole)), 167(C12H9N 
(Carbazole)), 223 (C16H17N (Tert-
butylcarbazole)). 
 
Result of in vitro alpha amylase and alpha 






zole and butylcarbazole have been successfully 
synthesized by alkylation of carbazole. In vitro 
inhibitory assay of synthesized products on alpha 
amylase showed a significant increase in 
inhibitory effect of the alkylcarbazole derivatives 
with increasing chain length of alkyl group. 
 
The IC50 value of carbazole, methylcarbazole, 
ethylcarbazole, propylcarbazole, butylcarbazole 







Figure 1: Percentage inhibition of (A) alpha amylase 
enzyme by carbazole, methylcarbazole, 
ethylcarbazole, propylcarbazole, butylcarbazole and 
acarbose, and (B) alpha glucosidase enzyme by 
ethylcarbazole, propylcarbazole, butylcarbazole and 
acarbose. Key: (□) methyl carbazole, (∆) 
ethylcarbazole, (*) propylcarbazole, (▼) 
butylcarbazole, (●) carbazole, (X) acarbose 
 
and acarbose (reference drug) decreased with 
increase in chain length of alkyl groups. This 
shows that inhibitory effect towards alpha 
amylase and hence antidiabetic activity 
increased with increase in alkyl group chain 
length (Figure 1). The alpha amylase inhibitory 
activity of propyl and butyl carbazole was 
comparable to that of Acarbose. For 
alphaglucosidase inhibitory activity, the IC50 
values are 205.30, 153.93, 152.90 and 59.57 
µg/mL for ethylcarbazole, propylcarbazole, 
butylcarbazole and acarbose (reference drug) 
respectively. Carbazole, methylcarbazole and 20 
µg/mL ethylcarbazole did not inhibit the activity of 
alpha glucosidase (Figure 2). These results 
showed that the inhibitory effect of 
ethylcarbazole (40 – 100 µg/mL), 
propylcarbazole and butylcarbazole as compared 
with the reference drug (Acarbose) was not 
significant. 
 
One way of reducing hyperglycaemia is to inhibit 
the activities of alpha amylase and alpha 
glucosidase. This is because pancreatic alpha 
amylase catalyses the breaking down of starch 
into disaccharides and oligosaccharides while 
intestinal alpha glucosidase catalyzes the 
breakdown of disaccharides to release glucose 
which is later absorbed from small intestine into 
the blood circulation [9]. The alkyl carbazole 
compounds synthesized in this work inhibited 
alpha amylase activity and therefore may have 




Four alkyl-carbozoles (methyl-, ethyl-, propyl- 
and butyl- carbazoles) with anti-diabetic effect 
have been successfully synthesised. These 
compounds have significant inhibitory activities 
against alpha amylase but alpha glucosidase. 
Alkylation of carbazole increases the alpha 
amylase inhibitory effect of carbazole. This 
inhibitory effect is directly proportional to the 
chain length of the alkyl group. Alkyl carbazole 
compounds could therefore serve as lead for 
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